References
Abildstrom SZ, Køber L, Torp-Pederse C. Epidemiology of arrhythmic and sudden death in the chronic phase of ischemic heart disease. Cardiac Electrophysiology Review 1999;3:177–179.
Torp-Pedersen C, Køber L, Elming H, Burchart H. Classification of sudden and arrhythmic death. Pacing Clin Electrophysiol 1997;20:2545–2552.
Abildstrom SZ, Torp-Pedersen C, Køber L. Definition of arrhythmic risk. In: Malik M(ed). Risk of Arrhythmia and Sudden Death. London: BMJ Books, 2001:10–18.
Hinkle-LE, Thaler HT. Clinical classification of cardiac deaths. Circulation 1982;65:457–464.
Greene HL, Richardson DW, Barker AH, Roden DM, Capone RJ, Echt DS, Friedman LM, Gillespie MJ, Hallstrom AP, Verter J. Classification of deaths after myocardial infarction as arrhythmic or nonarrhythmic (the Cardiac Arrhythmia Pilot Study). Am J Cardiol 1989;63:1–6.
AVID. Causes of death in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial. J Am Coll Cardiol 1999;34:1552–1559.
Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS, Mitchell LB, Green MS, Klein GJ, O'Brien B. Canadian implantable defibrillator study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000;101:1297–1302.
Kuck KH, Cappato R, Siebels J, Ruppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH). Circulation 2000;102(7): 748–754.
Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes DP, Greene HL, Boczor S, Domanski M, Follmann D, Gent M, Roberts RS. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. Eur Heart J 2000;21(24):2071–2078.
Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med1996;335:1933–1940.
Greene HL. Sudden arrhythmic cardiac death— mechanisms, resuscitation and classification: The Seattle perspective. Am J Cardiol 1990;65:4B–12B.
Pratt CM, Greenway PS, Schoenfeld MH, Hibben ML, Reiffel JA. Exploration of the precision of classifying sudden cardiac death. Implications for the interpretation of clinical trials. Circulation1996;93:519–524.
Kannel WB, Wilson PW, D'Agostino RB, Cobb J. Sudden coronary death in women. Am Heart J1998;136:205–212.
Cupples LA, Gagnon DR, Kannel WB. Long-and short-term risk of sudden coronary death. Circulation1992;85:I11–I18.
Rouleau JL, Talajic M, Sussex B, Potvin L, Warnica W, Davies RF, Gardner M, Stewart D, Plante S, Dupuis R, Lauzon C, Ferguson J, Mikes E, Balnozan V, Savard P. Myocardial infarction patients in the 1990s—their risk factors, stratification and survival in Canada: The Canadian Assessment of Myocardial Infarction (CAMI) Study. J Am Coll Cardiol 1996;27:1119–1127.
Marcus FI, Cobb LA, Edwards JE, Kuller L, Moss AJ, Bigger JTJ, Fleiss JL, Rolnitzky L, Serokman R. Mechanism of death and prevalence of myocardial ischemic symptoms in the terminal event after acute myocardial infarction. Am J Cardiol 1988;61:8–15.
Farrell TG, Bashir Y, Cripps T, Malik M, Poloniecki J, Bennett ED, Ward DE, Camm AJ. Risk stratification for arrhythmic events in postinfarction patients based on heart rate variability, ambulatory electrocardiographic variables and the signal-averaged electrocardiogram. J Am Coll Cardiol 1991;18:687–697.
Hartikainen JE, Malik M, Staunton A, Poloniecki J, Camm AJ. Distinction between arrhythmic and nonarrhythmic death after acute myocardial infarction based on heart rate variability, signalaveraged electrocardiogram, ventricular arrhythmias and left ventricular ejection fraction. J Am Coll Cardiol 1996;28:296–304.
Køber L, Torp-Pedersen C, Elming H, Burchardt H. Use of left ventricular ejection fraction or wallmotion score index in predicting arrhythmic death in patients following an acute myocardial infarction. The TRACE Study Group. Pacing Clin Electrophysiol1997;20:2553–2559.
Køber L, Torp-Pedersen C. Clinical characteristics and mortality of patients screened for entry into the Trandolapril Cardiac Evaluation (TRACE) study. Am J Cardiol 1995;76:1–5.
Julian DG, Camm AJ, Frangin G, Janse MJ, Munoz A, Schwartz PJ, Simon P. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators. Lancet1997;349:667–674.
Cairns JA, Connolly SJ, Roberts R, Gent M. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators. Lancet 1997;349: 675–682.
Bigger JT. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. N Engl J Med1997;337:1569–1575.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Abildstrom, S.Z., Torp-Pedersen, C. & Køber, L. Arrhythmic and Sudden Death in Chronic Ischemic Heart Disease—A Review of Epidemiological Data. Card Electrophysiol Rev 6, 5–8 (2002). https://doi.org/10.1023/A:1017935732134
Issue Date:
DOI: https://doi.org/10.1023/A:1017935732134